Across TCGA pan-cancer cohorts, FOXA2 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FOXA2 data layer compared with 10 for mutation status and 4 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FOXA2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FOXA2 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SCLC show a favorable association.
KIRC, HNSC, and KIRP are the cancer types where FOXA2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.